Dr. Dennis Roy Imperio, MD

Dr. Imperio practices at Fresenius Medical Care Sarasota Coastal Dialysis Center in Sarasota, Florida.

Dr. Imperio's NPI, 1417949611, was assigned on August 16, 2005. Dr. Imperio graduated from University of the Philippines College of Medicine in 1991. Dr. Imperio holds Florida license ME76037.

Dr. Imperio's primary practice is Fresenius Medical Care Sarasota Coastal Dialysis Center, at 1921 Waldemere St, Sarasota, FL 34239 in Sarasota County. The practice phone is (941) 373-9270.

Dr. Imperio's primary practice is Fresenius Medical Care Sarasota Coastal Dialysis Center in Sarasota, Florida. Dr. Imperio is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Florida Kidney Physicians. Dmand AI also links Dr. Imperio to 3 more hospitals, 3 dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Imperio practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Imperio's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Imperio is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Imperio's licenses on file in 2 states: Florida and Maryland.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and parathyroid gland disorder among the conditions Dr. Imperio treats.

CMS data shows 3,661 Medicare services from Dr. Imperio across 14 procedure codes in 2024, for 720 Medicare patients. Medicare paid $253,718 for them.

CMS counts 720 Medicare patients who saw Dr. Imperio in 2024. The largest group is 75 to 84, with 301 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 3.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Imperio's median patient age at 79, with 46% women.

In 2024, Dr. Imperio wrote 1,830 Medicare Part D claims for 315 patients. 84% of them were for generic drugs. CMS names the drug for 1,541 of them, across 30 drugs with 11 or more claims each, at $234,288 in total drug cost. In 2023, CMS named 1,269 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Imperio for performance year 2024, reported individually. Dr. Imperio accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Imperio. Dr. Imperio's most frequent co-author is John L. Cameron, MD.

CMS Open Payments shows 100 general payments to Dr. Imperio from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Relypsa, Inc. paid the most, $456.

Dr. Imperio graduated from University of the Philippines College of Medicine in 1991.

Dr. Imperio is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.